Femasys (NASDAQ: FEMY)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-10 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.240 | ||||||
REV | 321.405K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Femasys (NASDAQ: FEMY) through any online brokerage.
Other companies in Femasys’s space includes: Sonendo (NYSE:SONX), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO), Tivic Health Systems (NASDAQ:TIVC) and Motus GI Hldgs (NASDAQ:MOTS).
The latest price target for Femasys (NASDAQ: FEMY) was reported by Maxim Group on Friday, June 17, 2022. The analyst firm set a price target for 5.00 expecting FEMY to rise to within 12 months (a possible 148.76% upside). 5 analyst firms have reported ratings in the last year.
The stock price for Femasys (NASDAQ: FEMY) is $2.01 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Femasys.
Femasys’s Q2 earnings are confirmed for Wednesday, August 10, 2022.
There is no upcoming split for Femasys.
Femasys is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.